President Donald Trump Launches TrumpRx With 43 Discounted Drugs
The site lists 43 brand-name medicines with coupon codes and accepts only cash-paying customers, White House officials said.
Overview
President Donald Trump unveiled TrumpRx.gov on Feb. 5, 2026, listing 43 brand-name medications with coupon codes and links to participating pharmacies and manufacturers, White House officials said.
The portal is part of an administration effort to lower U.S. prescription costs after the White House negotiated with at least 16 drugmakers, according to administration officials.
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, called TrumpRx "transformative" during the Feb. 5 unveiling, while health policy experts cautioned the impact will be muted for roughly 85 percent of Americans with prescription drug coverage.
TrumpRx is limited to cash-paying patients and, the platform notes, purchases through the site do not count toward consumers' insurance deductibles, according to the website's terms.
The administration said it will add more drugs to the portal and urged Congress to pass the Great Healthcare Plan to enable insurance coverage for TrumpRx purchases, a move analysts say will determine the program's broader effect.
Analysis
Center-leaning sources frame TrumpRx cautiously, foregrounding limits and uncertainties through selective emphasis on cash-pay restriction, insurance noncoverage, launch delays and FOIA scrutiny. They highlight independent experts (KFF, Public Citizen) and contextual data (84% insured, 9-in-10 generics) while balancing White House claims, producing a skeptical-but-factual narrative.
Sources (20)
FAQ
TrumpRx is a government website (TrumpRx.gov) launched by President Donald Trump on February 5, 2026, offering discounts on 43 brand-name medications for cash-paying patients via coupon codes and links to pharmacies and manufacturers.
No, TrumpRx is only for cash-paying patients and purchases do not count toward insurance deductibles.
Initial participants include AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, with more drugs from other companies to be added soon.
Examples include fertility drugs like Gonal-F ($168 per pen), Cetrotide ($22.50), Ovidrel ($84), and inhalers like Bevespi Aerosphere ($51) and Airsupra ($201); GLP-1 drugs like Wegovy and Ozempic are $199/mo.
It is open to anyone with a prescription, but limited to cash-paying patients; discounts are unavailable for Medicare/Medicaid and do not affect insurance deductibles.
History
3 sources
- 14 sources
